中性粒细胞衍生的蛋白酶在肺炎:老玩家和新的前景

Coby J Cheetham1, Michael C McKelvey1, Daniel F McAuley2

  • 1Airway Innate Immunity Research (AiiR) Group, Wellcome-Wolfson Institute for Experimental Medicine and Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, UK.

概括

中性粒细胞蛋白酶驱动肺炎. 虽然中性粒细胞血清蛋白酶 (NSP) 在临床上取得了有限的成功,但像甲素这样的新型蛋白酶为炎症性肺部疾病提供了新的治疗点.